A
Anat Mirelman
Researcher at Tel Aviv Sourasky Medical Center
Publications - 246
Citations - 12440
Anat Mirelman is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Medicine & Gait (human). The author has an hindex of 47, co-authored 208 publications receiving 9246 citations. Previous affiliations of Anat Mirelman include Harvard University & Ben-Gurion University of the Negev.
Papers
More filters
Journal ArticleDOI
Using wearables to assess bradykinesia and rigidity in patients with Parkinson’s disease: a focused, narrative review of the literature
Itay Teshuva,Inbar Hillel,Eran Gazit,Nir Giladi,Nir Giladi,Anat Mirelman,Anat Mirelman,Jeffrey M. Hausdorff +7 more
TL;DR: Wearable technologies have the potential to improve the assessment and treatment of motor fluctuations and symptoms of PD more generally through real-time objective monitoring of bradykinesia and rigidity through the use of wearables.
Journal ArticleDOI
Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy.
S. Nicolai,Anat Mirelman,Talia Herman,Agnes Zijlstra,Martina Mancini,Clemens Becker,Ulrich Lindemann,Daniela Berg,Walter Maetzler,Walter Maetzler +9 more
TL;DR: This study is the first to demonstrate that audio-biofeedback training with PSP patients is associated with improvements of balance and psychosocial aspects, and it is demonstrated that the Parkinson’s disease questionnaire was demonstrated to be significantly improved.
Journal ArticleDOI
Associations between quantitative mobility measures derived from components of conventional mobility testing and Parkinsonian gait in older adults.
Aron S. Buchman,Sue Leurgans,Aner Weiss,Veronique G.J.M. VanderHorst,Anat Mirelman,Robert J. Dawe,Lisa L. Barnes,Robert S. Wilson,Jeffrey M. Hausdorff,David A. Bennett +9 more
TL;DR: In this article, the authors provide objective measures which characterize mobility in older adults assessed in the community setting and examine the extent to which these measures are associated with parkinsonian gait.
Journal ArticleDOI
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
Roberto A. Ortega,Cuiling Wang,Deborah Raymond,Nicole Bryant,Clemens R. Scherzer,Avner Thaler,Roy N. Alcalay,Andrew B. West,Anat Mirelman,Yuliya I. Kuras,Karen Marder,Nir Giladi,Laurie J. Ozelius,Susan Bressman,Rachel Saunders-Pullman +14 more
TL;DR: In this paper, the authors evaluated the association of leucine-rich repeat kinase 2(LRRK2G2019S) and glucocerebrosidase (GBA) variants with longitudinal cognitive and motor decline in PD.
Journal ArticleDOI
Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism
B.F.L. van Nuenen,Rick C. Helmich,Rick C. Helmich,M.U. Ferraye,Avner Thaler,Talma Hendler,Avi Orr-Urtreger,Anat Mirelman,Susan B. Bressman,Karen Marder,Nir Giladi,B.P.C. van de Warrenburg,Bastiaan R. Bloem,Ivan Toni +13 more
TL;DR: It is suggested that altered movement-related activity in the caudate nuclei of leucine-rich repeat kinase 2-G2019S carriers might remain behaviourally latent by virtue of cortical compensatory mechanisms involving long-range connectivity between the dorsal premotor cortex and posterior sensory regions.